Literature DB >> 16232609

Purification and characterization of a novel cyclohexylamine oxidase from the cyclohexylamine-degrading Brevibacterium oxydans IH-35A.

H Iwaki1, M Shimizu, T Tokuyama, Y Hasegawa.   

Abstract

Cyclohexylamine oxidase (CHAO) from a cell extract of Brevibacterium grown on cyclohexylamine was purified 50.2-fold, to electrophoretic homogeneity, by serial chromatographies. The molecular mass of the native enzyme was estimated to be approximately 50 kDa by gel filtration and SDS-PAGE. The optimum pH was 7.4 and the stable pH range was 6.0 to 7.0. The enzyme was thermostable up to 30 degrees C. The enzyme was found to be highly specific for the deamination of alicyclic monoamines such as cyclopentylamine, cycloheptylamine, and N-methylcyclohexylamine and aliphatic monoamines, such as sec-butylamine. The apparent K(m) value for cyclohexylamine was 1.23 mM. The enzyme was inhibited by flavin enzyme inhibitors such as quinine and quinacrine. The N-terminal 27 amino acid residues were determined as Gly-Ser-Val-Thr-Pro-Asp-Pro-Asp-Val-Asp-Val-Ile-Ile-His-Gly-Ala-Gly-Ile-Ser-Gly-Ser-Ala-Ala-Ala-Lys-Ala-Leu-, revealing homology to conventional flavin-containing amine oxidases (EC 1.4.3.4).

Entities:  

Year:  1999        PMID: 16232609     DOI: 10.1016/s1389-1723(00)80007-9

Source DB:  PubMed          Journal:  J Biosci Bioeng        ISSN: 1347-4421            Impact factor:   2.894


  3 in total

1.  Characterization of a New Cyclohexylamine Oxidase From Acinetobacter sp. YT-02.

Authors:  Hui Zhou; Zheng-Gang Han; Ti Fang; Yuan-Yuan Chen; Shang-Bo Ning; Ya-Ting Gan; Da-Zhong Yan
Journal:  Front Microbiol       Date:  2018-11-22       Impact factor: 5.640

2.  Complete Genome Sequence of Mameliella alba Strain KU6B, a Cyclohexylamine-Utilizing Marine Bacterium.

Authors:  Taisei Yamamoto; Yaxuan Liu; Yoshie Hasegawa; Hiroaki Iwaki
Journal:  Microbiol Resour Announc       Date:  2020-05-07

3.  Structural analysis of a novel cyclohexylamine oxidase from Brevibacterium oxydans IH-35A.

Authors:  I Ahmad Mirza; David L Burk; Bing Xiong; Hiroaki Iwaki; Yoshie Hasegawa; Stephan Grosse; Peter C K Lau; Albert M Berghuis
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.